Carvedilol
Product Images NDC 13107-142

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 13107-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Survival Analysis For Capricorn (intent-to-treat) (Carvedilol Fig1)

A line graph depicting percentage mortality over 24 months for Carvedilol versus placebo. The x-axis shows time in months, and the y-axis shows mortality percentage up to 30%. Two lines represent mortality trends: one for placebo, which is higher, and one for Carvedilol, which is lower. A p-value of 0.03 is displayed, indicating statistical significance.*

FDA Label Image

Figure 2. Effects On Mortality For Subgroups In Capricorn (Carvedilol Fig2)

A forest plot showing hazard ratios with confidence intervals for various patient subgroups related to myocardial infarction treatment factors. Subgroups include age, sex, timing of randomization post-MI, prior beta-blocker use, Killip classification, thrombolytic therapy, PTCA for MI, presence of congestive heart failure, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure, with hazard ratios plotted on the x-axis.*

FDA Label Image

Package Label-principal Display Panel (3.125 mg (1000 Tablet Bottle))

Label for Carvedilol Tablets USP containing 3.125 mg per film-coated tablet. The label indicates the manufacturer as Aurolife Pharma LLC and the product is manufactured for Aurobindo Pharma USA, Inc. It shows storage conditions, dispensing cautions, and bottle count of 1000 tablets. The label also includes the NDC 13107-142-99 and advises pharmacists to provide a patient information leaflet.*

FDA Label Image

Package Label-principal Display Panel (6.25 mg (1000 Tablet Bottle))

Label for Carvedilol Tablets USP 6.25 mg, containing 1000 tablets. Manufactured by Aurolife Pharma LLC and Aurobindo Pharma USA, Inc., Dayton, NJ. The label includes storage instructions, dosage note, barcode, NDC 13107-143-99, and advises dispensing the patient information leaflet with the medication.*

FDA Label Image

Package Label-principal Display Panel (12.5 mg (1000 Tablet Bottle))

Carvedilol Tablets, USP 12.5 mg film-coated tablets label showing active ingredient strength and prescription status. The label indicates packaging of 1000 tablets and manufacturing by Aurolife Pharma LLC and Aurobindo Pharma USA, Inc., Dayton, NJ. Storage and dispensing instructions are included along with a revised date of 04/2011.*

FDA Label Image

Package Label-principal Display Panel (25 mg (1000 Tablet Bottle))

Label for Carvedilol Tablets USP 25 mg film-coated tablets by Aurolife Pharma LLC. The label states the package contains 1000 tablets and includes storage instructions, dosage advisories, and manufacturer details. It also specifies the product is Rx only and includes the Aurobindo Pharma USA logo.*

FDA Label Image

Carvedilol Structure (Carvedilol Str)

Chemical structure diagram of Carvedilol, showing its molecular arrangement with labeled functional groups and aromatic rings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.